Axcelis Technologies research snapshot
ACLS AI stock analysis currently reads Axcelis Technologies as a focused ion implantation equipment supplier with a clean balance sheet but facing a challenging near-term earnings and demand picture. The stock closed near $144 on July 10, 2026, down from $178, after a sharp July 2 decline on heavy volume. Market capitalization is approximately $4.41 billion based on 30.7 million shares. TTM revenue is approximately $845 million, TTM net income is approximately $101 million, and TTM EPS is $3.22, giving a trailing P/E near 44x. Q1 2026 net income fell to $9.2 million from $34.3 million in the prior quarter, a step-down that raises questions about near-term earnings power. The company holds $367 million in cash against minimal debt. The ACLS AI stock forecast remains conditional because semiconductor capital spending cycles, customer concentration, technology transitions, and the recent earnings compression can all change the price path.
Current price
Approximately $144 at the July 10, 2026 close, down sharply from the prior $178 level after a July 2 gap-down on elevated volume
Market cap
$4.41 billion based on approximately 30.7 million shares outstanding and a reference price near $144, consistent with multiple market data sources
AI score
55 / 100
Rating
Niche semiconductor ion implantation equipment franchise with a strong cash position and minimal debt, balanced by a sharp Q1 2026 earnings decline, elevated P/E, cyclical end-market exposure, and customer concentration risk
Trend status
Bearish short-term after a 19% single-day gap-down on July 2, with the price holding near $144 and needing to reclaim the $150 zone to signal stabilization
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Axcelis designs, manufactures, and services ion implantation equipment used by semiconductor chip makers. The business is a niche player in a specialized process step, with an installed base that generates recurring service and spare-part revenue. | Medium |
| Moat | Technology expertise, customer qualifications, and long service relationships create practical barriers. Competitors like Applied Materials and Lam Research also offer implanters, so the moat is relative rather than absolute and depends on Axcelis staying competitive in each implanter generation. | Low-medium |
| Management | Russell Low has led the company since 2019, navigating the post-COVID semiconductor boom and the subsequent normalization. Capital allocation has been disciplined, with a clean balance sheet and share repurchases. The Q1 2026 earnings step-down is the key near-term test of management credibility. | Medium |
| Financial trend | Revenue grew through the semiconductor upcycle, with FY2025 revenue near $839 million and net income near $120 million. Q1 2026 revenue was $199 million, but net income dropped to $9.2 million, reflecting higher costs, mix shifts, or lower utilization. Free cash flow was $49 million TTM. | Medium-high |
| Valuation | At $144, the trailing P/E is approximately 44x on reported TTM EPS of $3.22, and the forward P/E is around 38x. Price/sales is 5.2x and price/book is 4.2x. The earnings multiple is elevated for a cyclical niche equipment supplier, especially after the Q1 step-down. | Medium-high |
| Technical trend | The stock gapped down 19% on July 2 from $178 to near $144 and has been consolidating around that level. The price is below all major short-term moving averages after the break, and the next directional signal depends on whether $144 holds as support. | Medium |
| Risk level | Material risks include semiconductor capex cycle downturns, customer concentration (a few large chip makers drive most orders), technology disruption in ion implantation, gross margin pressure from product mix, and the elevated starting valuation. | Medium-high |
| AI confidence | Data confidence is high for reported results and market structure. Forecast confidence is low-medium because a cyclical semiconductor equipment supplier with a recent earnings decline and high P/E is inherently difficult to value with precision. | Medium data confidence |
| Investment certainty | ACLS has niche technology and a fortress balance sheet, but the current earnings trajectory and P/E multiple suggest limited margin of safety. Certainty depends on the semiconductor capex cycle, customer orders, and whether the Q1 step-down is a transitory event or a new normal. | Low-medium |
ACLS AI stock forecast
The ACLS AI stock forecast uses $144, TTM EPS of $3.22, and an audited three-year earnings and multiple model. The model produced a bearish value near $35, a base value near $101, and a bullish value near $195. These are scenario outputs, not price promises. The base and bearish scenarios both imply multiple compression from the current 44x P/E, reflecting the cyclical nature of semiconductor equipment earnings.
$175 to $215
More likely if semiconductor capex accelerates, Axcelis wins new customer qualifications, gross margins stabilize above 42%, earnings grow at 20% annually, and the market rewards the niche position with a 35x forward earnings multiple.
$90 to $115
More likely if the semiconductor equipment cycle normalizes, Q1 2026 proves to be a trough quarter with gradual recovery, earnings grow at a mid-single-digit rate, multiple compression continues toward 25x, and the strong cash position provides a valuation floor.
$30 to $42
More likely if semiconductor capex weakens further, customer concentration causes order cancellations, margins contract, earnings decline at 10% annually, and the market re-rates the stock toward 15x earnings to reflect cyclical risk.
ACLS AI technical analysis
ACLS AI technical analysis uses market data available at the July 12, 2026 cutoff. The stock experienced a 19% single-day gap-down on July 2 from $178 to near $144, breaking below all major short-term moving averages. The price has since been consolidating around the $144 level. Yahoo Finance and TradingView show elevated volume on the gap-down day and a neutral-to-bearish short-term indicator mix.
| Level | Value | Why it matters |
|---|---|---|
| Current price | ~$144 | Approximate July 10, 2026 close after consolidation following the July 2 gap-down. |
| Immediate support | $140 to $143 | The July 2 intraday low reached $141.67, with additional support possible near the round $140 level. |
| Deeper support | $130 to $135 | A zone of prior trading in May and June 2026 before the recent decline, representing the next downside test if $140 fails. |
| Near resistance | $150 to $155 | The first overhead zone after the gap-down. A reclaim of $150 would signal that selling pressure is easing. |
| Higher resistance | $165 to $178 | The pre-gap-down trading range. A return above $178 would fill the gap and suggest the cycle concerns may be overdone. |
| Moving averages | 20-day SMA ~$158, 50-day SMA ~$168, 100-day SMA ~$155, 200-day SMA ~$130 | Estimated from price history. The July 2 gap-down pushed the price below all short-term averages. The 200-day SMA near $130 may provide the next structural support. |
| Momentum | RSI(14) oversold after July 2 gap-down; volume spiked sharply | The indicator mix suggests short-term selling exhaustion without a confirmed reversal signal. |
| Volume and volatility | 1,037,599 shares on July 2 (elevated vs. 698,870 average) | Yahoo Finance reported the gap-down day volume well above the average daily volume, indicating strong participation in the sell-off. |
| Invalidation | A decisive close below $140 | A break below $140 would suggest the consolidation is failing and the next leg lower toward $130 may be starting. |
ACLS AI trading strategy
The ACLS AI trading strategy below is a rules-based research framework, not personal advice. It connects price action with semiconductor capex trends, customer orders, earnings momentum, gross margins, cash position, and the cyclical nature of ion implantation equipment demand.
Wait for ACLS to reclaim and hold above the $150 to $155 resistance zone on above-average volume, then look for confirmation from quarterly orders, gross margin stabilization, and analyst revision momentum before treating the move as a new uptrend.
A failed reclaim below $140, further earnings deterioration, customer order cancellations, or a broad semiconductor sell-off should reduce trend-following confidence.
If ACLS holds the $140 to $143 support area and the Q1 2026 earnings step-down is clarified as transitory, compare a rebound thesis with the base scenario near $90 to $115 and with normalized free cash flow rather than buying solely because the price has dropped.
Avoid assuming that a nearly 20% drop is a margin of safety if semiconductor capex guidance, customer orders, or gross margins are still deteriorating.
Track quarterly revenue and net income trajectory, gross margin trends, customer order and backlog data, cash and debt levels, share repurchases, semiconductor industry capex forecasts, and competitive developments in ion implantation technology.
Position sizing should reflect that a cyclical semiconductor equipment supplier with a 44x trailing P/E can see rapid multiple compression when earnings turn down.
Investment research summary
Clients pay Axcelis for ion implantation equipment and related service and spare-part support used in semiconductor chip fabrication. Revenue is split between new equipment sales to chip makers and aftermarket lifecycle products and services, with the installed base providing recurring revenue and customer stickiness.
Axcelis benefits from specialized ion implantation technology expertise, customer qualification processes that create switching costs, and long-standing service relationships with semiconductor manufacturers. The moat is practical rather than absolute because large competitors like Applied Materials and Lam Research also offer implantation solutions and have broader customer access.
The thesis fails if semiconductor capital spending enters a prolonged downturn, key customers reduce or cancel orders, ion implantation technology is disrupted by alternative process techniques, gross margin compresses from product mix or pricing pressure, or the elevated starting P/E compresses sharply when earnings normalize.
Russell Low and his team have maintained a clean balance sheet with $367 million in cash and minimal debt, navigated the post-COVID boom-bust cycle, and returned capital through share repurchases. The Q1 2026 earnings step-down is the critical test of whether management can navigate the cyclical downturn while protecting margins and market share.
Long-term semiconductor demand is supported by AI, data centers, automotive electronics, and IoT, but the industry remains cyclical with periodic capex booms and busts. Ion implantation is a mature but essential process step, so Axcelis benefits from industry growth without being exposed to the fastest-changing lithography or etch segments.
At $144, ACLS trades at 44x trailing EPS with a forward P/E near 38x. The three-year scenario model produces a base value near $101 and a bearish value near $35, suggesting limited margin of safety at the current price. The strong cash position provides some downside protection, but the earnings trajectory remains the dominant valuation driver.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| ACLS price reference | Approximately $144 as of July 10, 2026 | Yahoo Finance and TradingView price data | July 12, 2026 |
| Market capitalization verification | $4.41 billion calculated from ~$144 x 30.7 million shares | Pineify financial_rigor.py and TradingView | July 12, 2026 |
| Shares outstanding | Approximately 30.7 million shares; TradingView reports 30.30 million float shares | TradingView and Yahoo Finance | July 12, 2026 |
| TTM revenue | Approximately $845 million TTM revenue; FY2025 revenue was $839 million | Yahoo Finance and TradingView | July 12, 2026 |
| TTM net income and EPS | TTM net income approximately $101 million; FY2025 net income was $120 million; TTM EPS $3.22 | Yahoo Finance and TradingView | July 12, 2026 |
| Q1 FY2026 results | $198.96 million revenue, $9.21 million net income, $0.72 EPS (beat estimate of $0.71) | TradingView earnings data | July 12, 2026 |
| Cash and debt | $366.6 million total cash; total debt/equity of 6.75% | Yahoo Finance balance sheet | July 12, 2026 |
| Free cash flow | Approximately $49 million levered free cash flow TTM | Yahoo Finance cash flow data | July 12, 2026 |
| Valuation cross-check | 44x trailing P/E, approximately 38x forward P/E, 5.2x price/sales, 4.2x price/book | Pineify financial_rigor.py with Yahoo Finance and TradingView data | July 12, 2026 |
| Technical snapshot | Price ~$144 after gap-down from $178; 52-week range $65.64 to $193.78; beta 1.28 | Yahoo Finance and TradingView technical data | July 12, 2026 |
This ACLS AI stock analysis is an informational research tool only and is not investment advice, tax advice, or a recommendation to buy or sell any security. Forecast scenarios are based on available public data as of July 12, 2026, and can be wrong if Axcelis execution, customer orders, semiconductor capex, gross margins, competition, technology disruption, or market valuation changes.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
